Emerging Pathogen Researchers are scientists who study newly identified or re-emerging infectious agents that pose significant threats to global health. These may include novel viruses, drug-resistant bacteria, and previously unknown pathogens capable of causing outbreaks or pandemics. Their work involves identifying and characterizing these organisms, studying how they spread, and understanding their interaction with the human immune system. Using advanced techniques such as genomic sequencing, molecular diagnostics, and bioinformatics, they help uncover the origins and evolution of emerging pathogens.
Beyond the lab, these researchers collaborate with epidemiologists, ecologists, and public health agencies to monitor disease trends and predict future threats. They contribute to the development of rapid diagnostic tests, vaccines, and therapeutics, often working under urgent timelines during health emergencies. Their findings are critical for early warning systems and global outbreak preparedness. They also assess environmental and behavioral factors—such as climate change, urbanization, and wildlife trade—that influence pathogen emergence. By advancing scientific knowledge and guiding public health interventions, Emerging Pathogen Researchers play a pivotal role in safeguarding global health security. They help design pathogen surveillance frameworks that span across human, animal, and environmental health sectors. Their input is vital in shaping risk communication strategies and guiding international travel and trade policies. They often work in high-containment labs, testing countermeasures for deadly infectious agents. Many contribute to global collaborative databases that track pathogen evolution in real time. Their dedication enables health systems to respond faster and more effectively to unknown biological threats.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation